EUVIMED · CrossrefZeitschrift
Current Hematologic Malignancy Reports
ISSN 1558-822X · Springer Science and Business Media LLC
Neueste Artikel
Thrombotic and Hemorrhagic Events in Myeloproliferative Neoplasms
Approach to Patients with Multiple Myeloma after BCMA targeted Therapy
The Influence of Social Determinants of Health on Treatment Delivery and Outcomes in Acute Leukemia
The Evolving Landscape of Reduced-Intensity Conditioning: Balancing Efficacy and Toxicity Across Hematologic Malignancies
Linking Air Pollution and Hematologic Malignancies: From Epidemiology to Molecular Mechanisms
Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era
Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia
Correction: Clonal Signatures of Telomere Biology Disorders
BRAF Alterations in Chronic Lymphocytic Leukemia: Genomic Landscape, Co-Mutation Patterns, and Clinical Relevance
Germline DDX41 Variants: Current Understanding and Future Directions
Clonal Signatures of Telomere Biology Disorders
Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms
The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes
Monoclonal Gammopathy-Associated Neuropathy
Emerging Therapeutic Approaches for Anemia in Myelofibrosis
The Role of Inflammation in CMML Pathobiology and Progression
Myelodysplastic syndromes: Updates on Genomic Landscape, Molecular Subtypes, & Targeted Therapies
Diagnosis and Management of Pulmonary Manifestations of Telomere Biology Disorders
Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications
Update on T-Cell Lymphoma Epidemiology
Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic Syndromes
An Update on the Management of Advanced Phase Chronic Myeloid Leukemia
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases
GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation
CAR-T Cell Therapy: the Efficacy and Toxicity Balance
Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia
Clonal Hematopoiesis and Myeloid Neoplasms in the Context of Telomere Biology Disorders
EUVIMED